8-K ·Filed Apr 17, 2026

OSUR

ORASURE TECHNOLOGIES INC
NEUTRAL
Impact 5/10
Horizonweeks Processed5mo ago SEC0001193125-26-160336
8-K material event: Items 1.01
Actionable Insight • Neutral

The resolution of the proxy fight removes a significant overhang on the stock. While this is a positive for governance stability, the core business fundamentals remain unchanged. Monitor the company's execution on its stated strategy for revenue growth and margin improvement.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
OSUR ▲ +34.81% at T+60d
NEUTRAL call ✓ call won +34.81% · α vs SPY +28.67% · entry $3.16 → $4.26
Entry anchored
Apr 16, 03:59 PM ET
via exchange tick
T+1d
+0.95%
call +0.95% · α +1.14%
$3.19
settled 6mo ago
T+5d
-5.06%
call -5.06% · α -5.62%
$3.00
settled 5mo ago
T+20d
-6.65%
call -6.65% · α -12.02%
$2.95
settled 5mo ago
T+60d
+34.81%
call +34.81% · α +28.67%
$4.26
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

OraSure Technologies has entered into a cooperation agreement with activist investor Altai Capital, resolving a proxy contest. The agreement includes the appointment of John D. Bertrand to the board, a commitment to declassify the board structure, and a standstill from Altai. This ends a governance dispute and stabilizes leadership.

Key Financial Metrics

Deal Type
other

Key Facts

  • Resolved proxy contest with activist investor Altai Capital.
  • Appointed John D. Bertrand to the Board of Directors.
  • Agreed to seek shareholder approval to declassify the board structure.
  • Altai Capital withdrew its director nominations and agreed to a standstill.

Financial Impact

The agreement resolves a governance dispute, potentially reducing uncertainty. The company will reimburse Altai for expenses up to $560,000.

governancelegal expenses

Risk Factors

  • The underlying reasons for the activist campaign (e.g., strategic direction, performance) may not be fully resolved.
  • The company's commitment to declassify the board could make it more vulnerable to future activist campaigns.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-160336
Document: d144249d8k.htm0001193125-26-160336
Document: d144249dex991.htm0001193125-26-160336
Document: 0001193125-26-160336-index-headers.html0001193125-26-160336
Document: 0001193125-26-160336-index.html0001193125-26-160336
Document: 0001193125-26-160336.txt0001193125-26-160336
14 reports for OSUR
Performance horizon
100% Hit rate 6 of 6 directional calls best @ T+60▲ +39.73%Mar 13, 2026
Filters
Rows
Reports for OSUR — sortable, filterable
TypeNow
Jul 23, 2026
10w ago
Court Ruling
NEUTRAL ★ 3/10
$4.03 $3.74▼ −7.20%▼ −10.50%$3.99 (−0.99%)
Jun 12, 2026
16w ago
Institutional Cluster
MIXED ★ 4/10
$4.18 $4.30▲ +2.75%▲ +0.97%$3.99 (−4.55%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$4.17 $4.35▲ +4.32%▲ +5.69%$3.99 (−4.32%)
May 6, 2026
21w ago
8-K
BEARISH ★ 6/10
$3.13 $3.95▼ −26.20%▼ −23.06%$3.99 (−27.48%)
Apr 22, 2026
23w ago
Press Release
BEARISH ★ 7/10
$3.05 $3.07▼ −0.66%▲ +3.98%$3.99 (−30.82%)
Apr 17, 2026
24w ago
DEFA14A
BULLISH ★ 7/10
$3.16 $2.95▼ −6.65%▼ −12.02%$3.99 (+26.27%)
Apr 17, 2026
24w ago
DEFA14A
BULLISH ★ 7/10
$3.16 $2.95▼ −6.65%▼ −12.02%$3.99 (+26.27%)
Apr 17, 2026
24w ago
8-K
NEUTRAL ★ 5/10
$3.16 $2.95▼ −6.65%▼ −12.02%$3.99 (+26.27%)
Mar 20, 2026
28w ago
Insider Cluster
NEUTRAL ★ 2/10
$2.95 $3.00▲ +1.53%▼ −7.79%$3.99 (+35.25%)
Mar 17, 2026
28w ago
DEFA14A
MIXED ★ 6/10
$2.90 $3.21▲ +10.69%▲ +4.64%$3.99 (+37.59%)
Showing 10 of 14

US Market Status

Market Open — Closes in 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access